Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEGN
2101
DELISTED
Aegion Corp
AEGN
| $7.54M | ﹤0.01% |
474,862
+9,523
| +2% | +$142K |
|
2102
Weibo
WB
$1.96B
| $7.53M | ﹤0.01% |
224,963
+18,030
| +9% | +$619K |
|
|
CKH
2103
DELISTED
Seacor Holdings Inc.
CKH
| $7.52M | ﹤0.01% |
265,433
+17,276
| +7% | +$472K |
|
|
ALX
2104
Alexander's
ALX
$1.4B
| $7.5M | ﹤0.01% |
31,116
+248
| +0.8% | +$66.5K |
|
2105
The RealReal
REAL
$1.51B
| $7.49M | ﹤0.01% |
585,322
+82,597
| +16% | +$983K |
|
2106
Krystal Biotech
KRYS
$9.57B
| $7.47M | ﹤0.01% |
180,346
+13,451
| +8% | +$647K |
|
|
HONE
2107
DELISTED
HarborOne Bancorp
HONE
| $7.45M | ﹤0.01% |
872,004
+198,516
| +29% | +$1.59M |
|
|
PAE
2108
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $7.42M | ﹤0.01% |
+776,757
| New | +$6.92M |
|
|
TVTY
2109
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $7.4M | ﹤0.01% |
653,424
-11,790
| -2% | -$108K |
|
2110
E.W. Scripps
SSP
$265M
| $7.4M | ﹤0.01% |
845,409
+26,804
| +3% | +$215K |
|
2111
Ecovyst
ECVT
$1.25B
| $7.38M | ﹤0.01% |
557,844
+23,637
| +4% | +$278K |
|
|
ABTX
2112
DELISTED
Allegiance Bancshares
ABTX
| $7.36M | ﹤0.01% |
289,841
+4,535
| +2% | +$111K |
|
2113
American Public Education
APEI
$981M
| $7.36M | ﹤0.01% |
248,534
-9,216
| -4% | -$258K |
|
2114
1-800-Flowers.com
FLWS
$265M
| $7.33M | ﹤0.01% |
366,268
-14,808
| -4% | -$292K |
|
|
CPRX
2115
DELISTED
Catalyst Pharmaceutical
CPRX
| $7.27M | ﹤0.01% |
1,574,492
+33,135
| +2% | +$149K |
|
|
TECX
2116
Tectonic Therapeutic
TECX
$558M
| $7.26M | ﹤0.01% |
34,685
+4,922
| +17% | +$1.01M |
|
2117
Neurogene
NGNE
$715M
| $7.25M | ﹤0.01% |
21,824
+7,279
| +50% | +$1.9M |
|
2118
CAE Inc. Common Shares
CAE
$8.63B
| $7.24M | ﹤0.01% |
447,530
+16,939
| +4% | +$262K |
|
2119
Interface
TILE
$2.05B
| $7.22M | ﹤0.01% |
887,388
+21,889
| +3% | +$186K |
|
2120
GSK
GSK
$103B
| $7.2M | ﹤0.01% |
141,185
-7,580
| -5% | -$389K |
|
|
BBT
2121
Beacon Financial Corp
BBT
$2.7B
| $7.18M | ﹤0.01% |
651,612
+24,065
| +4% | +$309K |
|
2122
e.l.f. Beauty
ELF
$5.15B
| $7.17M | ﹤0.01% |
376,164
+3,394
| +0.9% | +$48.6K |
|
|
NPTN
2123
DELISTED
NEOPHOTONICS CORP
NPTN
| $7.17M | ﹤0.01% |
807,517
-215,887
| -21% | -$1.86M |
|
2124
Banc of California
BANC
$3.07B
| $7.17M | ﹤0.01% |
661,697
-5,831
| -0.9% | -$58.6K |
|
|
SRG
2125
Seritage Growth Properties
SRG
$140M
| $7.16M | ﹤0.01% |
628,452
+21,227
| +3% | +$214K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.